These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2425335)

  • 21. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
    Wanitkun S
    J Pediatr; 2005 Jan; 146(1):149-50; author reply 150-1. PubMed ID: 15644851
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
    Sangtawesin C; Kirawitaya T; Layangkool T; Nawasiri W; Vimolsarawong N
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S656-60. PubMed ID: 14700163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kawasaki's disease. Presentation of 2 clinical cases].
    Cataldo F; Violante M; Donzelli M; Bellia L; La Monaca P
    Pediatr Med Chir; 1987; 9(1):99-103. PubMed ID: 3628061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kawasaki syndrome.
    Shackelford PG; Strauss AW
    N Engl J Med; 1991 Jun; 324(23):1664-6. PubMed ID: 1709447
    [No Abstract]   [Full Text] [Related]  

  • 25. Kawasaki syndrome and the eye.
    Smith LB; Newburger JW; Burns JC
    Pediatr Infect Dis J; 1989 Feb; 8(2):116-8. PubMed ID: 2468129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of Kawasaki syndrome by intravenous gamma globulins. A medium-term clinical and paraclinical study of 5 cases].
    Lebranchu Y; Despert F; Borderon JC; Bloc D; Renoux M; Bardos P; Laugier J
    Ann Pediatr (Paris); 1986 Nov; 33(9):809-13. PubMed ID: 3492169
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adult multiple coronary aneurysms of Kawasaki's disease's sequelae; two autopsy cases].
    Ohni S; Goto S; Nakamura H; Yamada T; Taira M; Sakurai I
    Rinsho Byori; 1998 Feb; 46(2):177-81. PubMed ID: 9528343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.
    Rowley AH; Duffy CE; Shulman ST
    J Pediatr; 1988 Aug; 113(2):290-4. PubMed ID: 2456378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy with high-dose intravenous gamma globulin in the newborn infant with thrombocytopenia from passive immunization].
    Ronconi GF; Castaman G; Fantuz E; Rodeghiero F
    Pediatr Med Chir; 1985; 7(4):567-8. PubMed ID: 2426684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 15-year review of children with Kawasaki's Syndrome having general anesthesia or deep sedation.
    Morrison JE; Anderson M; Chan KC; Pietra B; Zuk J; Gnadinger P
    Paediatr Anaesth; 2005 Dec; 15(12):1053-8. PubMed ID: 16324023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose gammaglobulin therapy for Kawasaki disease.
    Nagashima M; Matsushima M; Matsuoka H; Ogawa A; Okumura N
    J Pediatr; 1987 May; 110(5):710-2. PubMed ID: 2437278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose intravenous gammaglobulin for Kawasaki disease.
    Furusho K; Sato K; Soeda T; Matsumoto H; Okabe T; Hirota T; Kawada S
    Lancet; 1983 Dec; 2(8363):1359. PubMed ID: 6196587
    [No Abstract]   [Full Text] [Related]  

  • 33. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
    Wada Y; Kamei A; Fujii Y; Ishikawa K; Chida S
    J Pediatr; 2006 Mar; 148(3):399-400. PubMed ID: 16615977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intravenous gamma globulins (i.v.IG) in the treatment and prevention of virus infections].
    Bucholc B
    Przegl Epidemiol; 1992; 46(3):231-6. PubMed ID: 1338350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of primary immunodeficiencies with intravenous gamma globulin].
    García Rodríguez C; López Trascasa M; Ferreira Cerdán A; Fontán Casariego G
    An Esp Pediatr; 1987 Dec; 27(6):411-5. PubMed ID: 2451892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease.
    Muta H; Ishii M; Furui J; Nakamura Y; Matsuishi T
    Acta Paediatr; 2006 Feb; 95(2):189-93. PubMed ID: 16449025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kawasaki disease. Some recent studies on pathogenetic mechanisms.
    Tay JS
    J Singapore Paediatr Soc; 1990; 32(1-2):11-3. PubMed ID: 1701839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular complications of Kawasaki disease: clinical cases].
    Sica F; d'Amato E; Colapietra T; Romondia A
    Pediatr Med Chir; 1995; 17(6):531-3. PubMed ID: 8668589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.